Literature DB >> 32712734

Predictors for non-delayed discharge after transcatheter aortic valve replacement: utility of echocardiographic parameters.

Tomoo Nagai1, Hitomi Horinouchi2, Yohei Ohno2, Tsutomu Murakami2, Katsuaki Sakai2, Gaku Nakazawa2, Koichiro Yoshioka2, Yuji Ikari2.   

Abstract

Considering that transcatheter aortic valve replacement (TAVR) procedures have become less invasive, the duration for monitoring patient care after a successful TAVR can be reduced. Therefore, this study aimed to investigate the prognostic value of baseline echocardiographic parameters for non-delayed discharge in patients after TAVR. The study group included 154 consecutive patients (mean age: 84.4 ± 4.5 years; and 101 women) who underwent a TAVR. Comprehensive echocardiograms including both side indices of myocardial performance (IMP) and blood tests were obtained prior to the TAVR procedure. The median post-TAVR length of stay was 6 days while the mode and first quartile were both 4 days. Receiver operating characteristic curve analysis showed that the optimum cut-off value of the left-sided IMP in patients with a normal left ventricular ejection fraction (LVEF, ≥ 50%) (n = 124) for non-delayed discharge (≤ 4 days) was 0.34 with an area under the curve (AUC) value of 0.71563 and p value of < 0.0001, while the optimum cut-off value in patients with reduced LVEF (< 50%) (n = 30) was 0.47 with an AUC value of 0.77778 and p value of < 0.0120. An adjusted analysis indicated the negative left-sided IMP results as the only predictor for non-delayed discharge (p < 0.0001). Furthermore, the adjusted predictors for survival without early cardiovascular re-hospitalization within 6 months after TAVR were the positive left-sided IMP result, when the cut-off value of 0.52 was used, and the presence of elevated RAP of 8 to 15 mmHg. The early discharge policy should be carefully considered in high-risk populations, but the left-sided IMP may play a significant role in the pre-screening process.

Entities:  

Keywords:  Aortic valve stenosis; Echocardiogram; Transcatheter aortic valve replacement

Mesh:

Year:  2020        PMID: 32712734     DOI: 10.1007/s10554-020-01944-z

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  37 in total

1.  EuroSCORE II.

Authors:  Samer A M Nashef; François Roques; Linda D Sharples; Johan Nilsson; Christopher Smith; Antony R Goldstone; Ulf Lockowandt
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-29       Impact factor: 4.191

2.  Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).

Authors:  Matthew R Reynolds; Elizabeth A Magnuson; Kaijun Wang; Yang Lei; Katherine Vilain; Joshua Walczak; Susheel K Kodali; John M Lasala; William W O'Neill; Charles J Davidson; Craig R Smith; Martin B Leon; David J Cohen
Journal:  Circulation       Date:  2012-02-03       Impact factor: 29.690

3.  Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.

Authors:  Eric Durand; Hélène Eltchaninoff; Alexandre Canville; Najime Bouhzam; Matthieu Godin; Christophe Tron; Carlos Rodriguez; Pierre-Yves Litzler; Fabrice Bauer; Alain Cribier
Journal:  Am J Cardiol       Date:  2015-01-31       Impact factor: 2.778

4.  Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.

Authors:  Jeffrey J Popma; G Michael Deeb; Steven J Yakubov; Mubashir Mumtaz; Hemal Gada; Daniel O'Hair; Tanvir Bajwa; John C Heiser; William Merhi; Neal S Kleiman; Judah Askew; Paul Sorajja; Joshua Rovin; Stanley J Chetcuti; David H Adams; Paul S Teirstein; George L Zorn; John K Forrest; Didier Tchétché; Jon Resar; Antony Walton; Nicolo Piazza; Basel Ramlawi; Newell Robinson; George Petrossian; Thomas G Gleason; Jae K Oh; Michael J Boulware; Hongyan Qiao; Andrew S Mugglin; Michael J Reardon
Journal:  N Engl J Med       Date:  2019-03-16       Impact factor: 91.245

5.  Early discharge after transfemoral transcatheter aortic valve implantation.

Authors:  Marco Barbanti; Piera Capranzano; Yohei Ohno; Guilherme F Attizzani; Simona Gulino; Sebastiano Immè; Stefano Cannata; Patrizia Aruta; Vera Bottari; Martina Patanè; Claudia Tamburino; Daniele Di Stefano; Wanda Deste; Daniela Giannazzo; Giuseppe Gargiulo; Giuseppe Caruso; Carmelo Sgroi; Denise Todaro; Emanuela di Simone; Davide Capodanno; Corrado Tamburino
Journal:  Heart       Date:  2015-06-15       Impact factor: 5.994

6.  Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study.

Authors:  Paola D'Errigo; Marco Barbanti; Marco Ranucci; Francesco Onorati; Remo Daniel Covello; Stefano Rosato; Corrado Tamburino; Francesco Santini; Gennaro Santoro; Fulvia Seccareccia
Journal:  Int J Cardiol       Date:  2012-05-26       Impact factor: 4.164

7.  A pathway to earlier discharge following TAVI: Assessment of safety and resource utilization.

Authors:  Rebecca L Noad; Nicola Johnston; Andrew McKinley; Mark Dougherty; O C Nzewi; Reuben Jeganathan; Ganesh Manoharan; Mark S Spence
Journal:  Catheter Cardiovasc Interv       Date:  2015-05-23       Impact factor: 2.692

8.  Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Michael J Reardon; Nicolas M Van Mieghem; Jeffrey J Popma; Neal S Kleiman; Lars Søndergaard; Mubashir Mumtaz; David H Adams; G Michael Deeb; Brijeshwar Maini; Hemal Gada; Stanley Chetcuti; Thomas Gleason; John Heiser; Rüdiger Lange; William Merhi; Jae K Oh; Peter S Olsen; Nicolo Piazza; Mathew Williams; Stephan Windecker; Steven J Yakubov; Eberhard Grube; Raj Makkar; Joon S Lee; John Conte; Eric Vang; Hang Nguyen; Yanping Chang; Andrew S Mugglin; Patrick W J C Serruys; Arie P Kappetein
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

9.  A Prospective Analysis of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation.

Authors:  Anna Serletis-Bizios; Eric Durand; Guillaume Cellier; Christophe Tron; Fabrice Bauer; Bastien Glinel; Jean-Nicolas Dacher; Alain Cribier; Helene Eltchaninoff
Journal:  Am J Cardiol       Date:  2016-06-27       Impact factor: 2.778

10.  Evolution of Length of Stay After Surgical and Transcatheter Aortic Valve Implantation Over 8 Years in 1,849 Patients >75 Years of Age and Comparison Between Transfemoral and Transsubclavian Transcatheter Aortic Valve Implantation.

Authors:  Amedeo Anselmi; Annamaria Dachille; Vincent Auffret; Majid Harmouche; Antoine Roisne; Marc Bedossa; Hervé Le Breton; Jean-Philippe Verhoye
Journal:  Am J Cardiol       Date:  2018-07-20       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.